Skip to main content

Hidradenitis Suppurativa

Hidradenitis Suppurativa

Featured

Derm Q&A
Findings from a recent study showed patients with HS have a similar incidence to other well-studied, at-risk patient groups of opioid use, including those with newly diagnosed musculoskeletal pain. Lead study author Sarah Reddy discusses the implications of these findings and the role dermatologists play in identifying patients at-risk for opioid misuse.
News
Findings from a recent study showed patients with hidradenitis suppurativa experienced significant delays in receiving a diagnosis, and these delays were associated with more severe disease burden.
News
A recent poster study, presented at AAD VMX 2020, showed that adalimumab effectively reduced hidradenitis suppurativa activity among patients at an outpatient dermatology center.
News
Findings from a recent study showed major depressive disorder was associated with an increased risk of autoimmune skin diseases, including hidradenitis suppurativa.
News
Findings from a recent study indicated that several comorbidities precede a diagnosis of hidradenitis suppurativa, and that several develop afterwards.
Back to Top